Incident Stroke Tied to Acute, Accelerated Long-Term Cognitive Decline
By Elana Gotkine HealthDay Reporter
THURSDAY, Oct. 3, 2024 -- For older stroke survivors, incident stroke is associated with acute and accelerated long-term cognitive decline, according to a study published online Oct. 2 in JAMA Network Open.
Jessica W. Lo, from the University of New South Wales in Sydney, and colleagues mapped the trajectory of cognitive function before and after stroke in global cognition and in four cognitive domains in a study using harmonized and pooled data from 14 population-based cohort studies. The analyses included 20,860 participants (mean age, 72.9 years) who were followed for 7.51 years.
The researchers observed an association between incident stroke and a substantial acute decline in global cognition (−0.25 standard deviation [SD]), the Mini-Mental State Examination, and all cognitive domains (ranging from −0.17 to −0.22 SD) relative to a stroke-free cognitive trajectory. In addition, there was accelerated decline in global cognition (−0.038 SD per year) and all domains except memory (ranging from −0.020 to −0.055 SD per year). Compared with the rate of decline in individuals without stroke, no significant difference in prestroke slope was seen in stroke survivors in all cognitive measures. In global cognition, the mean rate of decline without a previous stroke was −0.049 SD per year.
"Targeting modifiable vascular risk factors at an early stage may reduce the risk of stroke but also subsequent risk of stroke-related cognitive decline and cognitive impairment," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
GLP-1 Receptor Agonists Tied to Decrease in T2DM-Related Dementia Risk
WEDNESDAY, July 23, 2025 -- Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with reduced type 2 diabetes mellitus (T2DM)-related dementia risk compared with...
Risk for Dementia, Ischemic Stroke, Mortality Lower With GLP-1 Receptor Agonists in T2D, Obesity
TUESDAY, July 22, 2025 -- For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for dementia, stroke...
Dementia Risk Does Not Differ With GLP-1 RAs, DPP4is for Seniors With T2DM
MONDAY, July 21, 2025 -- For older adults with diabetes, there is no clear evidence to suggest that the incidence of dementia differs for those using glucagon-like peptide 1...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.